Droperidol

Specifications

548-73-2CAS Number

208-957-8EC Number

3-[1-[4-(4-fluorophenyl)-4-oxobutyl]-3,6-dihydro-2H-pyridin-4-yl]-1H-benzimidazol-2-oneIUPAC Name

C22H22FN3O2Chemical Formula

379.4 g/molMolecular Weight

droperidol; 548-73-2; Droleptan; Dehydrobenzperidol; Inapsine; Dridol; Properidol; Sintodril; Sintosian; Halkan; Inapsin; Deidrobenzperidolo; Inopsin; McN-JR-4749; Droperidolo; Droperidolum; R-4749; DTXSID6022973; 1-(1-(3-(p-Fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone; 1-(1-(4-(p-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone; R4749; NSC-169874; O9U0F09D5X; NSC169874; 2H-Benzimidazol-2-one, 1-(1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridinyl)-1,3-dihydro-; CHEBI:4717; DTXCID302973; 2H-Benzimidazol-2-one, 1-[1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl]-1,3-dihydro-; 1-[1-[3-(p-Fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone; 1-{1-[4-(4-Fluoro-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one; 1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydropyridin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one; 2-Benzimidazolinone, 1-(1-(3-(p-fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-; 1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl}-2,3-dihydro-1H-benzo[d]imidazol-2-one; 1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydropyridin-4-yl}-2,3-dihydro-1H-1,3-benzodiazol-2-one; 1-[1-[4-(p-Fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone; 2-Benzimidazolinone, 1-[1-[3-(p-fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl]-; 1-(1-[3-(p-fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone; 1-(1-(4-(4-Fluoro-phenyl)-4-oxo-butyl)-1,2,3,6-tetrahydro-pyridin-4-yl)-1,3-dihydro-benzoimidazol-2-one; 1-(1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridinyl)-2,3-dihydro-1H-benzo(d)imidazol-2-one; 1-(1-(4-(4-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridin-4-yl)-1,3-dihydro-2H-benzimidazol-2-one; 1-(1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridin-4-yl)-2,3-dihydro-1H-1,3-benzodiazol-2-one; 1-(4-fluorophenyl)-4-(4-(2-hydroxy-1H-1,3-benzodiazol-1-yl)-1,2,3,6-tetrahydropyridin-1-yl)butan-1-one; 1-(4-fluorophenyl)-4-[4-(2-hydroxy-1H-1,3-benzodiazol-1-yl)-1,2,3,6-tetrahydropyridin-1-yl]butan-1-one; RefChem:57748; N01AX01; N05AD08; 208-957-8; DHBP; Vetkalm; Innovar; Thalamonal; Inappin; Innovan; Leptofen; Inoval; Innovar-vet; Dehidrobenzperidol; Thalamanol; Dihidrobenzperidol; C22H22FN3O2; McN-JR 4749; component of Innovar; R 4749; 3-[1-[4-(4-fluorophenyl)-4-oxobutyl]-3,6-dihydro-2H-pyridin-4-yl]-1H-benzimidazol-2-one; NSC 169874; 1-(1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridin-4-yl)-1H-benzo[d]imidazol-2(3H)-one; MFCD00083290; CHEMBL1108; MLS000028671; 1-[1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl]-1,3-dihydro-2h-benzimidazol-2-one; Dehydrobenzoperidol; s4096; NCGC00016504-01; CAS-548-73-2; Droperidolo [DCIT]; SMR000058855; 3-[1-[4-(4-fluorophenyl)-4-oxo-butyl]-3,6-dihydro-2H-pyridin-4-yl]-1H-benzimidazol-2-one; Droperidolum [INN-Latin]; Neurolidol; Ina.psi.ne; Ina.psi.n; Ino.psi.n; Droleptan (TN); 1-(1-(4-(4-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridinyl)-1,3-dihydro-2H-benzimidazol-2-one; 3-[1-[4-(4-fluorophenyl)-4-oxidanylidene-butyl]-2,3,4,5-tetrahydropyridin-4-yl]-1~{H}-benzimidazol-2-one; CCRIS 9070; HSDB 3320; SR-05000001546; INAPSINE (TN); EINECS 208-957-8; BRN 0579168; UNII-O9U0F09D5X; Droperiol; Droperidol CRS; Droperidol; 1-[1-[4-(4-Fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydropyridin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one; Prestwick_705; Innovar (Salt/Mix); Droperidol [USAN:USP:INN:BAN:JAN]; HS-0065; Leptanal (Salt/Mix); Leptofen (Salt/Mix); Droperidol (Standard); Spectrum_001220; Thalamonal (Salt/Mix); DROPERIDOL [MI]; DROPERIDOL [INN]; DROPERIDOL [JAN]; Innovar-vet (Salt/Mix); Opera_ID_1751; Prestwick0_000360; Prestwick1_000360; Prestwick2_000360; Prestwick3_000360; Spectrum2_001386; Spectrum3_001426; Spectrum4_000407; Spectrum5_001305; DROPERIDOL [HSDB]; DROPERIDOL [USAN]; DROPERIDOL [VANDF]; DROPERIDOL [MART.]; DROPERIDOL [USP-RS]; DROPERIDOL [WHO-DD]; SCHEMBL41426; BSPBio_000459; BSPBio_003132; KBioGR_000674; KBioSS_001700; 5-24-02-00388 (Beilstein Handbook Reference); MLS000758203; MLS001148120; MLS001424134; MLS002153445; DivK1c_000103; SPECTRUM1501002; SPBio_001372; SPBio_002380; BPBio1_000505; Droperidol (JP18/USP/INN); GTPL7172; orb1224710; orb1310097; orb3141140; DROPERIDOL [GREEN BOOK]; DROPERIDOL [ORANGE BOOK]; SCHEMBL29364550; HMS500F05; HY-B1240R; KBio1_000103; KBio2_001700; KBio2_004268; KBio2_006836; KBio3_002352; DROPERIDOL [EP MONOGRAPH]; NINDS_000103; DROPERIDOL [USP MONOGRAPH]; HMS1569G21; HMS1921B03; HMS2051L06; HMS2092O16; HMS2096G21; HMS2232M09; HMS3374B05; HMS3393L06; HMS3652M12; HMS3713G21; HMS3885N03; HMS5082K12; Pharmakon1600-01501002; INNOVAR COMPONENT DROPERIDOL; HY-B1240; MSK11416; Tox21_110461; BDBM50017705; CCG-39004; EBC-08486; NSC757819; AKOS015960779; Tox21_110461_1; AC-3537; CCG-101004; CS-4886; DB00450; FF22616; NC00254; NSC-757819; 1-1-[3-(p-Fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl-2-benzimidazolinone; IDI1_000103; NCGC00016504-02; NCGC00016504-03; NCGC00016504-04; NCGC00016504-05; NCGC00016504-06; NCGC00016504-09; NCGC00016504-10; NCGC00016504-17; NCGC00094884-01; NCGC00094884-02; DA-52701; USS; SBI-0051628.P002; Droperidol 1.0 mg/ml in Dimethyl Sulfoxide; NS00000026; SW220019-1; D00308; EN300-127036; F17346; AB00052191_04; AB00052191_05; WLN: T56 BMVNJ D3- DT6N CUTJ A3VR DF; F812033; L001006; Q174259; SR-05000001546-1; SR-05000001546-2; SR-05000001546-3; BRD-K97158071-001-05-8; BRD-K97158071-001-08-2; BRD-K97158071-001-17-3; BRD-K97158071-001-18-1; Z1592690523; Droperidol, British Pharmacopoeia (BP) Reference Standard; Droperidol, European Pharmacopoeia (EP) Reference Standard; Droperidol, United States Pharmacopeia (USP) Reference Standard; 2H-Benzimidazol-2-one,2,3,6-tetrahydro-4-pyridinyl]-1,3-dihydro-; 1-[1-[3-(p-Fluorobenzoyl)propyl]-1,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone; 1-[1-[4-(p-Fluorophenyl)-4-oxobutyl]-1,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone; 1-1-[3-(p-Fluorobenzoyl)propyl]-1,3,6-tetrahydro-4-pyridyl-2-benzimidazolinone; gamma-[4-(2-oxo-1-benzimidazolinyl)-1,2,3,6-tetrahydro-1-pyridyl]-p-fluorobutyrophenone; 1-(1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one; 1-[1-[4-(4-fluorophenyl)-4-oxo-butyl]-3,6-dihydro-2H-pyridin-4-yl]-3H-benzoimidazol-2-one; 1-{1-[4-(4-Chloro-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one(Droperidol); 1-{1-[4-(4-Fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydropyridin-4-yl}-1,3-dihydro-2H-1,3-benzimidazol-2-one; 1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,5,6-tetrahydropyridin-4-yl] -1,3-dihydro-2H-benzimidazol}-2-oneSynonyms